Literature DB >> 20820846

Mechanistic principles of RAF kinase signaling.

Christian M Udell1, Thanashan Rajakulendran, Frank Sicheri, Marc Therrien.   

Abstract

The RAF family of kinases are key components acting downstream of receptor tyrosine kinases and cells employ several distinct mechanisms to strictly control their activity. RAF transitions from an inactive state, where the N-terminal regulatory region binds intramolecularly to the C-terminal kinase domain, to an open state capable of executing the phosphoryl transfer reaction. This transition involves changes both within and between the protein domains in RAF. Many different proteins regulate the transition between inactive and active states of RAF, including RAS and KSR, which are arguably the two most prominent regulators of RAF function. Recent developments have added several new twists to our understanding of RAF regulation. Among others, dimerization of the RAF kinase domain is emerging as a crucial step in the RAF activation process. The multitude of regulatory protein-protein interactions involving RAF remains a largely untapped area for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820846     DOI: 10.1007/s00018-010-0520-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  160 in total

1.  Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis.

Authors:  L Wojnowski; L F Stancato; A C Larner; U R Rapp; A Zimmer
Journal:  Mech Dev       Date:  2000-03-01       Impact factor: 1.882

Review 2.  KSR and CNK: two scaffolds regulating RAS-mediated RAF activation.

Authors:  A Clapéron; M Therrien
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

3.  A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity.

Authors:  G Tzivion; Z Luo; J Avruch
Journal:  Nature       Date:  1998-07-02       Impact factor: 49.962

4.  Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338.

Authors:  A Chaudhary; W G King; M D Mattaliano; J A Frost; B Diaz; D K Morrison; M H Cobb; M S Marshall; J S Brugge
Journal:  Curr Biol       Date:  2000-05-04       Impact factor: 10.834

5.  IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.

Authors:  Monideepa Roy; Zhigang Li; David B Sacks
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling.

Authors:  B Diaz; D Barnard; A Filson; S MacDonald; A King; M Marshall
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.

Authors:  Nicholas Trakul; Raymond E Menard; George R Schade; Zhijian Qian; Marsha Rich Rosner
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

8.  Functional analysis of the regulatory requirements of B-Raf and the B-Raf(V600E) oncoprotein.

Authors:  T Brummer; P Martin; S Herzog; Y Misawa; R J Daly; M Reth
Journal:  Oncogene       Date:  2006-05-15       Impact factor: 9.867

Review 9.  Taming the Hippo: Raf-1 controls apoptosis by suppressing MST2/Hippo.

Authors:  Eric O'Neill; Walter Kolch
Journal:  Cell Cycle       Date:  2005-03-08       Impact factor: 4.534

10.  Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression.

Authors:  A M Cacace; N R Michaud; M Therrien; K Mathes; T Copeland; G M Rubin; D K Morrison
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

View more
  34 in total

Review 1.  Regulation of protein kinases by lipids.

Authors:  Thomas A Leonard; James H Hurley
Journal:  Curr Opin Struct Biol       Date:  2011-12       Impact factor: 6.809

2.  Cancer: A drug-resistant duo.

Authors:  Hugo Lavoie; Marc Therrien
Journal:  Nature       Date:  2011-12-14       Impact factor: 49.962

Review 3.  Canonical RTK-Ras-ERK signaling and related alternative pathways.

Authors:  Meera V Sundaram
Journal:  WormBook       Date:  2013-07-11

4.  Different Raf protein kinases mediate different signaling pathways to stimulate E3 ligase RFFL gene expression in cell migration regulation.

Authors:  Xiaoqing Gan; Chen Wang; Maulik Patel; Barry Kreutz; Maggie Zhou; Tohru Kozasa; Dianqing Wu
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

5.  Tyr728 in the kinase domain of the murine kinase suppressor of RAS 1 regulates binding and activation of the mitogen-activated protein kinase kinase.

Authors:  Claudia Sibilski; Thomas Mueller; Laxmikanth Kollipara; René P Zahedi; Ulf R Rapp; Thomas Rudel; Angela Baljuls
Journal:  J Biol Chem       Date:  2013-10-24       Impact factor: 5.157

Review 6.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

7.  Time-resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK.

Authors:  Peter Kubiniok; Hugo Lavoie; Marc Therrien; Pierre Thibault
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

8.  Apical accumulation of the Sevenless receptor tyrosine kinase during Drosophila eye development is promoted by the small GTPase Rap1.

Authors:  Caroline Baril; Martin Lefrançois; Malha Sahmi; Helene Knævelsrud; Marc Therrien
Journal:  Genetics       Date:  2014-06-03       Impact factor: 4.562

9.  Phosphorylation of BRAF by AMPK impairs BRAF-KSR1 association and cell proliferation.

Authors:  Che-Hung Shen; Ping Yuan; Rolando Perez-Lorenzo; Yaqing Zhang; Sze Xian Lee; Yang Ou; John M Asara; Lewis C Cantley; Bin Zheng
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

Review 10.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.